HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMMUNEONCO-B

6.440

-0.250-3.74%

Volume:428.40K

Turnover:2.77M

Market Cap:2.78B

PE:-6.99

High:6.700

Open:6.690

Low:6.410

Close:6.690

52wk High:16.800

52wk Low:4.310

Shares:432.00M

HK Float Shares:420.00M

Volume Ratio:0.50

T/O Rate:0.10%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.921

ROE:-53.53%

ROA:-25.66%

PB:4.73

PE(LYR):-6.99

PS:20.59

Loading ...

Overview Company News Filings

ImmuneOnco (01541) Announces Registered Share Capital Increase as of November 2025

Bulletin Express

ImmuneOnco Biopharmaceuticals Chairman/CEO Boosts Stake

MT Newswires Live

ImmuneOnco (1541 HK) Announces Chairman’s Shareholding Increase

Bulletin Express

BRIEF-Immuneonco Biopharmaceuticals Shanghai Inc Says CEO Purchases 50,000 H Shares At Average Price Of HK$6.6258 Each

IMMUNEONCO-B (01541) Executive Director Tian Wenzhi Increases Holdings by 50,000 H Shares

ImmuneOnco Biopharmaceuticals Shanghai Inc - CEO Purchases 50,000 H Shares at Average Price of HK$6.6258 Each

THOMSON REUTERS

HK Stock Movement | IMMUNEONCO-B (01541) Surges Over 9% in Afternoon Trading as IMM0306 Phase III Clinical Trial Plan Approved by CDE

IMMUNEONCO-B (01541): Drug Evaluation Center Approves Phase III Clinical Study Protocol for IMM0306 in Treating Relapsed/Refractory Follicular Lymphoma

ImmuneOnco (1541) Gains Approval for Phase III Clinical Protocol Targeting Relapsed/Refractory Follicular Lymphoma

Bulletin Express

Immuneonco Biopharmaceuticals Wins CDE Approval for Phase III Trial of IMM0306 in Follicular Lymphoma

ImmuneOnco Redeems Huatai Wealth Products, Subscribes to HK$120 Million Note; Shares Slip 5%

MT Newswires Live

ImmuneOnco (1541) Redeems Existing Wealth Products and Subscribes to HK$120 Million Product

Bulletin Express

IMMUNEONCO-B (01541) Subscribes to HK$120 Million Wealth Management Product

ImmuneOnco Biopharmaceuticals Shanghai's Chairman Purchases 50,000 H Shares

ImmuneOnco Biopharmaceuticals Chairman/CEO Boosts Stake

MT Newswires Live

BRIEF-ImmuneOnco Biopharmaceuticals Shanghai's Chairman Purchases 50,000 H Shares

IMMUNEONCO-B (01541) Executive Director Tian Wenzhi Increases Holdings by 50,000 H Shares

ImmuneOnco Biopharmaceuticals Shanghai - Chairman Purchases 50,000 H Shares at Average Price of HK$7.9500 per Share

THOMSON REUTERS

HK Short Interest Data as of October 31

ImmuneOnco Doses First Patient in Tumor Drug Study

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/01541/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"IMMUNEONCO-B","latestPrice":6.44,"timestamp":1765181290002,"preClose":6.69,"halted":0,"volume":428400,"delay":0,"floatShares":420000000,"shares":432000000,"eps":-0.9213707181400197,"marketStatus":"Not Yet Opened","change":-0.25,"latestTime":"12-08 16:08:10","open":6.69,"high":6.7,"low":6.41,"amount":2767185,"amplitude":0.043348,"askPrice":6.49,"askSize":200,"bidPrice":6.44,"bidSize":1400,"shortable":3,"etf":0,"ttmEps":-0.8457713346455161,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765243800000},"marketStatusCode":0,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":6.69,"openAndCloseTimeList":[[1765157400000,1765166400000],[1765170000000,1765180800000]],"volumeRatio":0.499977,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":420000000,"roa":"-25.66%","roe":"-53.53%","lyrEps":-0.921371,"volumeRatio":0.499977,"shares":432000000,"dividePrice":0,"high":6.7,"amplitude":0.043348,"preClose":6.69,"low":6.41,"week52Low":4.31,"pbRate":"4.73","psRate":"20.59","week52High":16.8,"institutionHeld":0,"latestPrice":6.44,"committee":0.75,"eps":-0.9213707181400197,"divideRate":0,"volume":428400,"delay":0,"ttmEps":-0.8457713346455161,"open":6.69,"prevYearClose":5.16,"prevWeekClose":6.69,"prevMonthClose":7.25,"prevQuarterClose":13.42,"fiveDayClose":6.86,"twentyDayClose":8.01,"sixtyDayClose":14.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post Market","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2025-12-05","current":-7.615224,"percent":0.66129,"low":-30.003263,"twenty":-19.073975,"median":-13.014894,"eighty":-6.44644,"high":-2.993766,"avg":-13.533945,"sd":7.247438,"marketCap":2886786479},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-16","current":-8.311097,"twenty":-24.799485,"median":-12.12195,"eighty":-5.751942,"marketCap":2843007711},{"date":"2025-05-23","current":-11.289802,"twenty":-24.776462,"median":-11.940532,"eighty":-5.771038,"marketCap":3873496179},{"date":"2025-05-30","current":-15.223569,"twenty":-24.763734,"median":-11.970101,"eighty":-5.797425,"marketCap":5246123111},{"date":"2025-06-06","current":-16.623143,"twenty":-24.617548,"median":-12.331836,"eighty":-5.827424,"marketCap":5743038499},{"date":"2025-06-13","current":-15.603079,"twenty":-24.258649,"median":-12.701975,"eighty":-5.862056,"marketCap":5392753881},{"date":"2025-06-20","current":-14.878015,"twenty":-24.00727,"median":-12.82804,"eighty":-5.90109,"marketCap":5132076957},{"date":"2025-06-27","current":-13.023121,"twenty":-23.933348,"median":-12.837907,"eighty":-5.91626,"marketCap":4504823106},{"date":"2025-07-04","current":-14.906416,"twenty":-23.89321,"median":-12.895238,"eighty":-5.935244,"marketCap":5156515418},{"date":"2025-07-11","current":-12.022018,"twenty":-23.818294,"median":-12.972072,"eighty":-5.957179,"marketCap":4154538489},{"date":"2025-07-18","current":-12.975089,"twenty":-23.597552,"median":-12.895238,"eighty":-5.971632,"marketCap":4480384645},{"date":"2025-07-25","current":-12.316929,"twenty":-23.410778,"median":-12.839078,"eighty":-5.984465,"marketCap":4268584643},{"date":"2025-08-01","current":-12.109688,"twenty":-23.260279,"median":-12.895238,"eighty":-5.992729,"marketCap":4170830796},{"date":"2025-08-08","current":-13.046774,"twenty":-23.142239,"median":-12.972072,"eighty":-6.013995,"marketCap":4504823106},{"date":"2025-08-15","current":-15.594562,"twenty":-23.052783,"median":-12.982136,"eighty":-6.023266,"marketCap":5376461574},{"date":"2025-08-22","current":-14.245172,"twenty":-22.717488,"median":-13.011166,"eighty":-6.052989,"marketCap":4895838493},{"date":"2025-08-29","current":-13.416028,"twenty":-22.485479,"median":-13.022379,"eighty":-6.061027,"marketCap":4439653875},{"date":"2025-09-05","current":-17.224047,"twenty":-22.314693,"median":-13.032106,"eighty":-6.075447,"marketCap":5694161576},{"date":"2025-09-12","current":-15.065483,"twenty":-22.014704,"median":-13.063177,"eighty":-6.087386,"marketCap":4989519263},{"date":"2025-09-19","current":-14.903882,"twenty":-21.818428,"median":-13.085834,"eighty":-6.113201,"marketCap":4932496186},{"date":"2025-09-26","current":-13.980202,"twenty":-21.168438,"median":-13.096763,"eighty":-6.121719,"marketCap":4614796184},{"date":"2025-10-03","current":-19.067762,"twenty":-21.059976,"median":-13.099741,"eighty":-6.122985,"marketCap":6309196195},{"date":"2025-10-10","current":-15.483575,"twenty":-20.658991,"median":-13.109708,"eighty":-6.128239,"marketCap":5115784649},{"date":"2025-10-17","current":-12.892469,"twenty":-20.520951,"median":-13.123492,"eighty":-6.17051,"marketCap":4256365412},{"date":"2025-10-24","current":-11.824326,"twenty":-20.411262,"median":-13.104868,"eighty":-6.183537,"marketCap":3905144639},{"date":"2025-10-31","current":-11.96327,"twenty":-20.170656,"median":-13.098863,"eighty":-6.223751,"marketCap":3956925563},{"date":"2025-11-07","current":-10.312858,"twenty":-19.984772,"median":-13.08999,"eighty":-6.257081,"marketCap":3408910790},{"date":"2025-11-14","current":-10.296734,"twenty":-19.520389,"median":-13.071805,"eighty":-6.311268,"marketCap":3413225867},{"date":"2025-11-21","current":-8.92105,"twenty":-19.161835,"median":-13.046774,"eighty":-6.362869,"marketCap":2955827710},{"date":"2025-11-28","current":-9.407815,"twenty":-19.096653,"median":-13.027047,"eighty":-6.414675,"marketCap":3128430788},{"date":"2025-12-05","current":-8.666243,"twenty":-19.073975,"median":-13.014894,"eighty":-6.44644,"marketCap":2886786479}],"updateTime":1765213709352},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1173544573","title":"ImmuneOnco (01541) Announces Registered Share Capital Increase as of November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1173544573","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173544573?lang=en_us&edition=fundamental","pubTime":"2025-12-04 17:03","pubTimestamp":1764839025,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (stock code: 01541) published a monthly return indicating a rise in registered share capital to RMB 420,477,305 for its H shares, from 396,277,305 in the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"gpt_icon":0},{"id":"2588743670","title":"ImmuneOnco Biopharmaceuticals Chairman/CEO Boosts Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2588743670","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588743670?lang=en_us&edition=fundamental","pubTime":"2025-12-04 10:48","pubTimestamp":1764816526,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals  said Chairman and Chief Executive Tian Wenzhi purchased 50,000 H shares on Dec. 3 at an average price of HK$6.6258, according to a Wednesday Hong Kong bourse filing.Shares of the firm were up over 3% in Thursday morning trade.The purchase lifted Tian's stake to over 116.1 million shares, or 26.91% of the company's issued capital.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"1154296209","title":"ImmuneOnco (1541 HK) Announces Chairman’s Shareholding Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=1154296209","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154296209?lang=en_us&edition=fundamental","pubTime":"2025-12-03 18:24","pubTimestamp":1764757455,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (the “Company”) reported that its Executive Director, Chief Executive Officer, and Chairman of the Board, Dr. Tian Wenzhi, acquired 50,000 H shares in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"gpt_icon":0},{"id":"2588017381","title":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Inc Says CEO Purchases 50,000 H Shares At Average Price Of HK$6.6258 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2588017381","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588017381?lang=en_us&edition=fundamental","pubTime":"2025-12-03 18:10","pubTimestamp":1764756637,"startTime":"0","endTime":"0","summary":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Inc Says CEO Purchases 50,000 H Shares At Average Price Of HK$6.6258 EachDec 3  - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:CEO PURCHASES 50,000 H SHARES AT AVERAGE PRICE OF HK$6.6258 EACHFurther company coverage: 1541.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X817A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-Immuneonco Biopharmaceuticals Shanghai Inc Says CEO Purchases 50,000 H Shares At Average Price Of HK$6.6258 Each","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"gpt_icon":0},{"id":"1155276718","title":"IMMUNEONCO-B (01541) Executive Director Tian Wenzhi Increases Holdings by 50,000 H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1155276718","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155276718?lang=en_us&edition=fundamental","pubTime":"2025-12-03 18:08","pubTimestamp":1764756506,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) announced that the board was informed by Dr. Tian Wenzhi that he purchased a total of 50,000 H shares of the company on the open market on December 3, 2025, at an average price...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2588012703","title":"ImmuneOnco Biopharmaceuticals Shanghai Inc - CEO Purchases 50,000 H Shares at Average Price of HK$6.6258 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2588012703","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588012703?lang=en_us&edition=fundamental","pubTime":"2025-12-03 18:05","pubTimestamp":1764756301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X817A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"1157057375","title":"HK Stock Movement | IMMUNEONCO-B (01541) Surges Over 9% in Afternoon Trading as IMM0306 Phase III Clinical Trial Plan Approved by CDE","url":"https://stock-news.laohu8.com/highlight/detail?id=1157057375","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157057375?lang=en_us&edition=fundamental","pubTime":"2025-11-27 13:56","pubTimestamp":1764222974,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) rose more than 9% in afternoon trading, reaching a 7.98% gain at press time to HK$7.31, with a turnover of HK$10.70 million. The company announced during the midday break that...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","LU1223083913.SGD","LU1223082196.USD","01541","CDE","III","BK4017","LU1223082519.USD","BK1161"],"gpt_icon":0},{"id":"1176417596","title":"IMMUNEONCO-B (01541): Drug Evaluation Center Approves Phase III Clinical Study Protocol for IMM0306 in Treating Relapsed/Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1176417596","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176417596?lang=en_us&edition=fundamental","pubTime":"2025-11-27 12:38","pubTimestamp":1764218293,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) announced that the company has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the Phase III clinical study...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","01541","III","BK1161"],"gpt_icon":0},{"id":"1147916824","title":"ImmuneOnco (1541) Gains Approval for Phase III Clinical Protocol Targeting Relapsed/Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1147916824","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147916824?lang=en_us&edition=fundamental","pubTime":"2025-11-27 12:20","pubTimestamp":1764217233,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (Stock Code: 1541) has obtained approval from the Center for Drug Evaluation of the National Medical Products Administration for a Phase III clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"gpt_icon":0},{"id":"2586535215","title":"Immuneonco Biopharmaceuticals Wins CDE Approval for Phase III Trial of IMM0306 in Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2586535215","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586535215?lang=en_us&edition=fundamental","pubTime":"2025-11-27 12:19","pubTimestamp":1764217165,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneonco Biopharmaceuticals  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on November 27, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nNDL7NzFrC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2585195355","title":"ImmuneOnco Redeems Huatai Wealth Products, Subscribes to HK$120 Million Note; Shares Slip 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585195355","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585195355?lang=en_us&edition=fundamental","pubTime":"2025-11-21 12:01","pubTimestamp":1763697674,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals  redeemed HK$49.6 million and HK$43.7 million of wealth management products from Huatai Financial, generating estimated interest income of HK$3.46 million and HK$1.27 million, according to a Thursday bourse filing.Shares of the firm were down nearly 5% in Friday's late morning trade.The redemptions represent the company's full holdings in the two Huatai products.On the same day, the company agreed to subscribe to a new HK$120 million structured note issued by Huatai International Financial Products, with a one-year term and an expected annualised return of 1.5% to 4.5%.The subscription was funded with internal surplus cash, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"1169998077","title":"ImmuneOnco (1541) Redeems Existing Wealth Products and Subscribes to HK$120 Million Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1169998077","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169998077?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:02","pubTimestamp":1763647344,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541) announced that it redeemed its entire holdings in two previously subscribed wealth management products from Huatai Financial on November 20, 2025....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"gpt_icon":0},{"id":"1177886263","title":"IMMUNEONCO-B (01541) Subscribes to HK$120 Million Wealth Management Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1177886263","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177886263?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:56","pubTimestamp":1763646971,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) announced that on November 20, 2025, the company notified Huatai Financial to redeem HK$49.6033 million (first redemption) and HK$43.72 million (second redemption) of Huatai...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2584929767","title":"ImmuneOnco Biopharmaceuticals Shanghai's Chairman Purchases 50,000 H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584929767","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584929767?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:05","pubTimestamp":1763571939,"startTime":"0","endTime":"0","summary":"Nov 7 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai Inc <1541.HK>::*CHAIRMAN PURCHASES 50,000 H SHARES AT AVERAGE PRICE OF HK$7.9500 PER SHARE*Further company coverage: 1541.HK* ((Reuters.Briefs@","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD27xQVV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2582465888","title":"ImmuneOnco Biopharmaceuticals Chairman/CEO Boosts Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2582465888","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582465888?lang=en_us&edition=fundamental","pubTime":"2025-11-10 12:38","pubTimestamp":1762749504,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals   said Chairman and Chief Executive Tian Wenzhi acquired 50,000 H shares in the open market on Friday at an average price of HK$7.95 per share, according to a same-day Hong Kong bourse filing.Shares of the firm were up nearly 2% in Monday's mid-day trade.Following the purchase, Tian holds nearly 116.1 million shares, representing 26.9% of the company's issued share capital.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2581009928","title":"BRIEF-ImmuneOnco Biopharmaceuticals Shanghai's Chairman Purchases 50,000 H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009928","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009928?lang=en_us&edition=fundamental","pubTime":"2025-11-07 18:59","pubTimestamp":1762513160,"startTime":"0","endTime":"0","summary":"BRIEF-ImmuneOnco Biopharmaceuticals Shanghai's Chairman Purchases 50,000 H SharesNov 7 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK:CHAIRMAN PURCHASES 50,000 H SHARES AT AVERAGE PRICE OF HK$7.9500 PER SHAREFurther company coverage: 1541.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-ImmuneOnco Biopharmaceuticals Shanghai's Chairman Purchases 50,000 H Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"gpt_icon":0},{"id":"1174217431","title":"IMMUNEONCO-B (01541) Executive Director Tian Wenzhi Increases Holdings by 50,000 H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1174217431","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174217431?lang=en_us&edition=fundamental","pubTime":"2025-11-07 18:42","pubTimestamp":1762512132,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) announced that the board was informed by Dr. Tian Wenzhi, the company's Executive Director, CEO, and Chairman of the Board, that he purchased a total of 50,000 H shares of the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2581800665","title":"ImmuneOnco Biopharmaceuticals Shanghai - Chairman Purchases 50,000 H Shares at Average Price of HK$7.9500 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2581800665","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581800665?lang=en_us&edition=fundamental","pubTime":"2025-11-07 18:32","pubTimestamp":1762511564,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"1154233358","title":"HK Short Interest Data as of October 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1154233358","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154233358?lang=en_us&edition=fundamental","pubTime":"2025-10-31 18:32","pubTimestamp":1761906770,"startTime":"0","endTime":"0","summary":"As of October 24, the top three stocks with the highest short interest ratios were ZTE (00763), China Vanke (02202), and COSCO SHIP HOLD (01919), with short interest ratios of 15.82%, 15.47%, and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1719994722.HKD","00763","LU0488056044.USD","LU0499858602.USD","LU1769817179.HKD","LU0164872284.USD","LU0072462343.USD","LU1051769294.HKD","LU0348788117.USD","LU0231483743.USD","LU0588546209.SGD","LU0882747503.HKD","LU2097828631.EUR","LU0320764599.SGD","IE00BGHQDM52.EUR","03800","LU0348735423.USD","LU0819123356.HKD","LU1813983027.USD","BK1207","LU0762541174.USD","LU1115378108.SGD","BK1518","HK0000306685.HKD","BK1574","IE00BVYPNQ40.USD","BK1529","LU0348767384.USD","LU1282648689.USD","00909","BK1169","LU1770036033.HKD","BK1515","HK0000306701.USD","LU0359201612.USD","LU1981816686.USD","LU0651946864.USD","LU0588545904.SGD","LU0384037296.USD","03993","LU1282649141.HKD","LU1770034418.SGD","HK0000252160.HKD","LU0828237510.HKD","LU0708995583.HKD","01772","LU0197773160.USD","LU0348827113.USD","LU0821914370.USD","LU0640798160.USD","LU0651947912.USD","LU0211977185.USD","BK1618","LU0140636845.USD","LU0417516571.SGD","LU0823426308.USD","LU1282649067.USD","LU0856984785.SGD","BK1109","LU0762540952.USD","LU0878004406.USD","LU0417516738.SGD","LU0456827905.SGD","LU0499858438.USD","SG9999004220.SGD","LU2476274308.USD","02158","BK1516","LU2399975544.HKD","LU0593848301.USD","LU1046422090.SGD","LU0314109678.HKD","LU0326950275.SGD","BK1526","LU0165289439.USD","LU1769817096.USD","HK0000252152.HKD","LU0469268626.HKD","LU0737861699.HKD","LU0878005551.USD","BK1550","06181","LU0588545490.SGD","BK1505","LU0650527681.SGD","LU0594300179.USD","LU1366334651.USD","BK1544","LU1048588211.SGD","LU0196878994.USD","LU1282649810.SGD","BK1506","LU0862451753.SGD","06865","LU0348816934.USD","LU0106252389.USD","LU0052750758.USD","BK1224","SGXZ86797644.SGD","LU0345775950.USD","SGXZ90724238.SGD","LU0164880469.USD","01171","LU0828237940.HKD","BK1583","LU0634319403.HKD","LU0228367735.SGD","BK1513","LU1515016050.SGD","LU0588545730.USD","LU0880133367.SGD","SG9999002463.SGD","LU1807302812.USD","LU1044875133.USD","02600","LU0266512127.USD","02318","BK1585","IE00BMCWC346.EUR","IE00BYV24P56.USD","01877","LU0039217434.USD","BK1594","06060","LU0918141887.USD","LU1044874839.SGD","LU2778985437.USD","SG9999002828.SGD","BK1571","LU0043850808.USD","LU0048580855.USD","BK1129","02899","BK1175","LU0315178854.USD","LU0327786744.USD","LU0348784397.USD","SG9999006597.SGD","LU1188198961.HKD","HK0000320264.USD","LU0762542818.HKD","09606","SG9999001069.SGD","BK1149","02202","LU0359201885.HKD","BK1535","LU1831875114.USD","LU0348783233.USD","01276","LU0501845795.SGD","LU0266512473.USD","LU1794554557.SGD","LU0345780521.USD","BK1589","601318","BK1183","LU1044876610.USD","LU0348814723.USD","LU1023057109.AUD","BK1610","LU2153592121.USD","LU1235295612.USD","LU0918141705.HKD","SG9999001051.SGD","LU1481107354.HKD","BK1103","02050","LU0061477393.USD","LU0149721374.USD","IE0034224299.USD","LU2097828805.USD","LU0791590937.USD","LU0611395673.USD","SG9999002562.SGD","IE00BZ08YT58.USD","LU1051768304.USD","HK0000500386.USD","LU0067412154.USD","LU0348783662.USD","IE0003895053.USD","LU2543165471.USD","BK1100","LU0197773673.USD","LU0345776255.USD","BK1191","PAImain","LU0054450605.USD","LU1642822792.SGD","BK1568","LU0072913022.USD","LU2348774022.SGD","IE00BZ08YR35.GBP","SG9999001440.SGD","BK1127","PNGAY","06821","BK1240","HK0000320223.HKD","LU2039709279.SGD","LU0106959298.USD","LU0051755006.USD","LU1720050803.USD","LU0886674414.USD","01919","LU2097828557.USD","BK1554","LU0819121731.USD","BK1184","LU1960683339.HKD","BK1136","LU2226246903.HKD","BK1227","LU0049853897.USD","BK1178","LU0235996351.USD","LU1224709979.USD","LU1993786604.SGD","SG9999003461.SGD","BK1521","LU1880383440.USD","LU0164865239.USD","LU0531971595.HKD","LU0254981946.USD","LU0463099449.HKD","SGXZ62798434.SGD","LU0630378692.HKD","LU1211504680.USD","IE00BVYPNP33.GBP","LU1303224171.USD","BK1116","LU0871576103.HKD","LU0648948544.HKD","00853","LU1226287529.USD","BK1613","HPAD.SI","03145","LU0831093199.SGD","LU0315179316.USD","LU0244354667.USD","BK1509","BK1198","09969","LU1105468828.SGD","LU2476274720.SGD","LU1880383366.USD","LU0348766576.USD","LU0630378429.USD","LU1048596156.SGD","LU0096374516.USD","LU0572944931.SGD","LU0287142896.SGD","BK1555","01787","LU0049112450.USD","IE00BZ08YS42.EUR","BK1619","LU1366334578.USD","SG9999002950.SGD","BK1507","LU2293587155.HKD","BK1617","SG9999014674.SGD","BK1607","LU0370786039.SGD","LU0228659784.USD","LU0328353924.USD","LU0561508036.HKD","09992","LU0594300419.USD","LU0181495838.USD","BK1161","03750","LU2488822045.USD","LU0605514214.HKD","LU0417516902.SGD","LU0456854461.SGD","LU0173614495.USD","LU0307460666.USD","LU0359202008.SGD","BK1592","02367","IE00BF5LJ272.USD","LU0348825331.USD","LU0865486749.SGD","LU1504937902.USD","LU0890818403.SGD","LU0797268264.HKD","LU0823426480.USD","BK1538","LU1328277881.USD","LU0449515922.USD","LU0084288322.USD","BK1189","01541","06682","82318","LU2097828474.EUR","LU2097828714.EUR","SG9999004311.SGD","LU0163747925.USD","LU1961090484.USD","LU0791591158.USD","BK1190","IE0008368742.USD","LU0345780281.USD","BK1117","LU0540923850.HKD","LU0348805143.USD","000002","LU1251922891.USD"],"gpt_icon":0},{"id":"2577057643","title":"ImmuneOnco Doses First Patient in Tumor Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2577057643","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577057643?lang=en_us&edition=fundamental","pubTime":"2025-10-23 19:22","pubTimestamp":1761218525,"startTime":"0","endTime":"0","summary":"ImmuneOnco Biopharmaceuticals (Shanghai) (HKG:1541) dosed the first patient in a phase IB/II clinical trial of IMM2510, a Thursday Hong Kong bourse filing said.The trial is testing the drug in combination with IMM01 for the treatment of advance solid tumors.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01541","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}]}}